The Use of PCSK9 Inhibitor Is Associated With More Adaptative Eating Behaviors Among Adults With Heterozygous Familial Hypercholesterolemia

Antzeko izenburuak

• The Use of PCSK9 Inhibitor Is Associated With More Adaptative Eating Behaviors Among Adults With Heterozygous Familial Hypercholesterolemia
  nork: Clémence Desjardins, et al.
  Argitaratua: (2025-05-01)
• Two Cases of Heterozygous Familial Hypercholesterolemia in Children Effectively Managed With Pitavastatin and Ezetimibe Combination Therapy
  nork: Katsufumi Nishioka, et al.
  Argitaratua: (2025-10-01)
• Effect of causative genetic variants on atherosclerotic cardiovascular disease in heterozygous familial hypercholesterolemia patients
  nork: Anthony Matta, et al.
  Argitaratua: (2023-07-01)
• Lipoprotein (a) levels in children with heterozygous familial hypercholesterolemia
  nork: Liliya F. Galimova, et al.
  Argitaratua: (2024-12-01)
• Lipoprotein-X: A Case of Falsely Elevated LDL Hypercholesterolemia
  nork: Jacob Y. Mok, MD, et al.
  Argitaratua: (2023-05-01)